Adenosine triphosphate

Bestqool Launches Innovative Red Light Therapy Devices for Eczema Relief

Retrieved on: 
Friday, April 5, 2024

Bestqool's advanced red light therapy offers a non-invasive, natural solution for managing this pervasive skin issue.

Key Points: 
  • Bestqool's advanced red light therapy offers a non-invasive, natural solution for managing this pervasive skin issue.
  • Combining red light therapy with topical ointments can be a complementary approach for effective eczema treatment.
  • Bestqool's latest range of portable red light therapy devices are designed to be both convenient and effective for home use.
  • Adding red light therapy to daily care and prevention can repair both inside and outside by lowering eczema recurrence and improving the quality of life.

FERROFECT® Helps Address Anemia

Retrieved on: 
Wednesday, March 27, 2024

FORT LAUDERDALE, Fla., March 27, 2024 /PRNewswire/ -- The body uses iron for many functions. Most of this iron is obtained through an individual's diet. However, when there is a chronic shortage of iron or the body struggles to synthesize it, it can be a problem. This can lead to iron deficiencies and anemia (the under-production of red blood cells, often due to a lack of iron). Three million Americans suffer from anemia, and WHO estimates that the condition globally impacts half a billion women and over a quarter of a billion children under the age of five.

Key Points: 
  • This can lead to iron deficiencies and anemia (the under-production of red blood cells, often due to a lack of iron).
  • Three million Americans suffer from anemia, and WHO estimates that the condition globally impacts half a billion women and over a quarter of a billion children under the age of five.
  • In addition, FERROFECT® helps with the production of adenosine triphosphate (ATP).
  • FERROFECT® even helps with DNA replication , a critical function required for cells to split and grow.

Celluma Light Therapy Introduces the RESTORE Hair Therapy System

Retrieved on: 
Thursday, March 14, 2024

TUSTIN, Calif., March 14, 2024 /PRNewswire/ -- BioPhotas, Inc., the makers of Celluma Light Therapy and market leader in therapeutic LED light therapy devices, announced today the launch of the RESTORE Hair Serum, an optimized scalp and hair formulation that complements the award-winning Celluma RESTORE LED device to provide a complete hair-restoration solution.

Key Points: 
  • TUSTIN, Calif., March 14, 2024 /PRNewswire/ -- BioPhotas, Inc., the makers of Celluma Light Therapy and market leader in therapeutic LED light therapy devices, announced today the launch of the RESTORE Hair Serum, an optimized scalp and hair formulation that complements the award-winning Celluma RESTORE LED device to provide a complete hair-restoration solution.
  • "It's an amazingly elegant formulation that is clear and easily absorbed into the scalp so that it can be used daily to maximize the Celluma Light Therapy results."
  • For the growing number of professionals and individuals achieving significant and visible results with the FDA-cleared Celluma RESTORE Light Therapy device for hair restoration, this serum is an ideal complement for use between each light therapy treatment.
  • According to Mr. Cluff, "the Celluma RESTORE light therapy device has been available since receiving FDA-clearance for hair restoration in 2021.

Clene Announces Peer-Reviewed Publication Describing CNM-Au8 Brain Target Engagement In Neurodegenerative Diseases

Retrieved on: 
Thursday, December 14, 2023

CNM-Au8 is an orally-delivered suspension of clean-surfaced, catalytically-active gold nanocrystals shown to have neuroprotective and neuroreparative properties in multiple preclinical models of neurodegenerative disease.

Key Points: 
  • CNM-Au8 is an orally-delivered suspension of clean-surfaced, catalytically-active gold nanocrystals shown to have neuroprotective and neuroreparative properties in multiple preclinical models of neurodegenerative disease.
  • Dr. Benjamin Greenberg, Head of Medical at Clene, said, “We believe the 10.4% increase in brain NAD+/NADH ratio to be clinically significant.
  • Other groups have shown significant deficits in brain energy metabolites associated with neurodegenerative disease.
  • Elevation of brain NAD+/NADH levels to many times the rate of loss observed in healthy aging is a significant and very promising effect.”

A Milestone Clinical Study Reveals that Elevating Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Supplementation Effectively Reduces Inflammation in Both Healthy Subjects and Immune Cells Derived from Psoriasis Patients

Retrieved on: 
Monday, October 2, 2023

The clinical trial was part of the ChromaDex External Research Program (CERP™), which donated ChromaDex’s patented nicotinamide riboside (NR) ingredient, Niagen, for the advancement of this research.

Key Points: 
  • The clinical trial was part of the ChromaDex External Research Program (CERP™), which donated ChromaDex’s patented nicotinamide riboside (NR) ingredient, Niagen, for the advancement of this research.
  • This is Dr. Sack’s fourth published study on NR, and the seventh clinical study overall, that demonstrates NR’s effectiveness in reducing inflammation, an important indicator of how the body is aging,” remarked Rob Fried, CEO of ChromaDex.
  • This is the third published human clinical study demonstrating that NR supplementation has a protective effect in healthy individuals and lays the foundation for future clinical research ( Elhassan et al.
  • Research suggests a depletion of NAD+ is associated with impaired inflammatory responses and innate immune dysfunction, indicating NAD+ levels may have a critical impact on the function of immune cells.

Govorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD Deficiency

Retrieved on: 
Thursday, May 25, 2023

Additionally, the Company announced that new data has been published in the Journal of Clinical Investigation on govorestat treatment in models of SORD Deficiency.

Key Points: 
  • Additionally, the Company announced that new data has been published in the Journal of Clinical Investigation on govorestat treatment in models of SORD Deficiency.
  • Applied Therapeutics has partnered govorestat for treatment of SORD Deficiency as well as Galactosemia in Europe with ADVANZ Pharma.
  • The new data on govorestat treatment in models of SORD Deficiency was recently published in the Journal of Clinical Investigation.
  • These findings uncover the molecular and cellular pathophysiology of sorbitol toxicity in SORD neuropathy, and govorestat provides a potential treatment strategy for patients with SORD Deficiency.

How much energy do we expend thinking and using our brain?

Retrieved on: 
Tuesday, April 25, 2023

But does our brain burn more energy when engaging in mental athletics than it does during other activities, such as watching TV?

Key Points: 
  • But does our brain burn more energy when engaging in mental athletics than it does during other activities, such as watching TV?
  • Tracing brain energy consumption can be done using both sugar and oxygen, but oxygen is the more accessible option.
  • Tracing oxygen consumption, the brain accounts for about 20% of the body’s energy consumption, despite only representing 2% of its weight.

How do we know?

    • We can’t measure brain energy consumption in humans in this way, but we can follow the oxygen, as increased brain activity requires more oxygen.
    • Research indeed shows increased mental load (such as performing mental arithmetic, reasoning, or multitasking) is linked to increased oxygen consumption (measured via CO₂ release).

Can we measure oxygen use just in the brain?

    • That extra supply of oxygen-rich blood is region specific and can be (literally) channelled with micrometre precision to active neurons.
    • Since blood and its oxygen are weakly attracted by magnetic fields, we can use MRI (magnetic resonance imaging), a radiation-free tool, to obtain an, albeit indirect, measure of brain activity.
    • But unfortunately, we can’t use MRI to tell us how much energy our brain uses for different mental activities.

So, how much does brain activity increase?

    • MRI studies have shown attentively monitoring moving objects compared to passively watching them increases brain activity in our visual cortex by around 1%.
    • But interestingly, processing visual information leads to a reduction of activity in auditory areas, meaning we spend less energy processing the sounds in our environment.
    • This works the other way around as well: when we attend to auditory information, we reduce our visual processing activity.

Then why do we feel exhausted after too much mental activity?

    • Complex mental tasks are typically also emotionally challenging and lead to increased activation of our sympathetic nervous system, ultimately leading to mental and physical fatigue.
    • The good news is we don’t have to worry that too much mental activity will drain our brain energy.

MEI Pharma Initiates Strategic Realignment

Retrieved on: 
Monday, December 5, 2022

As part of the realignment, the company plans to streamline its organization towards the development of two earlier clinical-stage assets, voruciclib and ME-344.

Key Points: 
  • As part of the realignment, the company plans to streamline its organization towards the development of two earlier clinical-stage assets, voruciclib and ME-344.
  • The company further announced that it has engaged Torreya Partners as financial advisor to help explore additional strategic opportunities.
  • We intend to continue development of our earlier-stage clinical assets, streamline MEIs operations towards these efforts, and consider additional strategic opportunities, said Daniel P. Gold, Ph.D., president and chief executive officer of MEI Pharma.
  • MEI Pharma, Inc. (Nasdaq: MEIP) is a pharmaceutical company focused on developing potential new therapies for cancer.

Neogen® Launches Synergize® Disinfectant in Europe, the Middle East, Africa

Retrieved on: 
Tuesday, November 15, 2022

LEXINGTON, Ky., Nov. 15, 2022 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched its trusted Synergize® disinfectant in Europe, the Middle East, and Africa.

Key Points: 
  • LEXINGTON, Ky., Nov. 15, 2022 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched its trusted Synergize disinfectant in Europe, the Middle East, and Africa.
  • "Our Synergize disinfectant has long been trusted in North America to protect people and animals," said John Adent, Neogen's President and CEO.
  • Synergize disinfectant is a combination quaternary ammonium and glutaraldehyde multi-purpose disinfectant that is non-corrosive to hard surfaces, killing both Gram-negative and Gram-positive bacteria, fungi, spores, and viruses.
  • Synergize will be launched at the EuroTier exhibition this week in Hannover, Germany, where Neogen will exhibit its full range of biosecurity solutions in Hall 23 D47.

Capillus Announces Launch of Market's Most Powerful Hair Restoration Cap

Retrieved on: 
Monday, November 14, 2022

MIAMI, Nov. 14, 2022 /PRNewswire/ -- Curallux, LLC, the leaders in laser therapy products for hair regrowth, has announced the launch of the Capillus MD, the first-ever medical-grade cap offering 320 laser diodes, and the category's most powerful hair restoration cap to date. The Capillus MD, which is FDA-cleared for the treatment of androgenetic alopecia, will be available on the market in March of 2023. With its powerful capacity, the new Capillus MD cap will be specially offered to the medical community including dermatologists, surgeons, and hair transplant centers.

Key Points: 
  • MIAMI, Nov. 14, 2022 /PRNewswire/ -- Curallux, LLC, the leaders in laser therapy products for hair regrowth, has announced the launch of the Capillus MD , the first-ever medical-grade cap offering 320 laser diodes, and the category's most powerful hair restoration cap to date.
  • With its powerful capacity, the new Capillus MD cap will be specially offered to the medical community including dermatologists, surgeons, and hair transplant centers.
  • Capillus caps help treat hair loss by delivering low-level laser therapy (LLLT) directly to the hair follicles, which is shown to increase cell metabolism for thicker hair.
  • The Capillus MD cap envelopes patients' scalp with 650 nanometer light that stimulates hair growth at the cellular level.